{"id":949477,"date":"2026-04-07T09:41:50","date_gmt":"2026-04-07T13:41:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/"},"modified":"2026-04-07T09:41:50","modified_gmt":"2026-04-07T13:41:50","slug":"milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/","title":{"rendered":"Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">MONTREAL and CHARLOTTE, N.C., April  07, 2026  (GLOBE NEWSWIRE) &#8212; Milestone<sup>\u00ae<\/sup> Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development of commercialization of innovative cardiovascular medicines, today announced that management will present at the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fOQxMo3ktGUv1zoUmDE-Benuo3idHLTd8Igl0ibVfyaHXxqMAW6_6xeElXE1Yrh8QpW-arTp2zDwqmxU4Dfck1yIXztNIqc7sejWd7F4vTYnwxJ_Gm3-Re15uCFULtq8r8xL_olJBTrakZJD80fIiTQVjfcHl5puWFBfS2wcG50=\" rel=\"nofollow\" target=\"_blank\">25<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BU-um13WKzJp3sW6zPo4BIlcgNRPZ6392peQ0jtDeyM-bbv4_tdnUQTngC9bq7-gRMLJCSGLiNM_8XQodhazTW0ptv7doRBHHIJJHulVQIsfIVGUwoRTsrByF7S7jFgpI379grOUdMCngFoxJKGYzwXvOkJAiyKGau5BpDA1rBU=\" rel=\"nofollow\" target=\"_blank\"><sup>th<\/sup><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_asv6FHGf4lWQIQezuY6nMN4WJd4iBfSw7-OXYyLuN_83VDsNCiI_idTSEuJCpgpMc0b6bTegigjuR5Q6MB6r-63a3HDBbUwzjM8ZGNcn4_0PFSuNAa4waE0zvBj2wM7ruDvwD-8c2f9ivfCsdD-EXxA740AIiGM-4rK6I8QT0helNCDDbvOwImbYtcoqSKAEmsKCF92Ef6eUvN_Mcy6iA==\" rel=\"nofollow\" target=\"_blank\"> Annual Needham Virtual Healthcare Conference<\/a> to take place April 13 &#8211; 16, 2026.<\/p>\n<p align=\"justify\">A webcast of the presentation will be available on April 13<sup>th<\/sup> at 3:45 PM EDT. The webcast will be available to watch <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=16oA94LTmQzZ2MdaJmtOtTSLRDWG8ZU57EOcSoaZ6flWQxyqXrtFDIUmwBmxM-VtHpjI1AHhcweB04ZQ_dc7a3yvpa54762zFoSmx4qLNr22QzqfHkqlIevtfw0YJaRIWJ4hQe0u0HNJ-GVq9SCOFCbxn2nmhUMDc6wXpyXvhyal-OT9wrCSvs3wrnI_2Nn0\" rel=\"nofollow\" target=\"_blank\">here<\/a> and there will be a replay for approximately 90 days on the News &amp; Events section of Milestone&#8217;s website www.milestonepharma.com.<\/p>\n<p align=\"justify\">If you are interested in meeting with the Milestone team during the conference, please contact your Needham representative.<\/p>\n<p align=\"justify\">\n        <strong>About\u00a0Milestone Pharmaceuticals<\/strong>\n      <\/p>\n<p align=\"justify\">Milestone Pharmaceuticals Inc.\u00a0(Nasdaq: MIST) is an emerging commercial-stage biopharmaceutical company advancing innovative cardiovascular medicines to benefit people living with certain heart conditions.\u00a0Milestone\u2019s lead product is CARDAMYST\u2122 (etripamil) nasal spray, a novel calcium channel blocker, which is FDA approved for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. Etripamil is also in development for the control of symptomatic episodic attacks associated with AFib-RVR.<\/p>\n<p align=\"justify\">\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>\n        <strong>Investor Relations<\/strong>\n      <\/p>\n<p>Kevin Gardner, kgardner@lifesciadvisors.com<\/p>\n<p align=\"justify\">\n        <strong>Media Relations<\/strong>\u00a0<\/p>\n<p align=\"justify\">Rebecca Novak,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dM2YWK08idgSFpBAxQ0QItfX_loQCxspsWPXaAJLZ_yNH49l_but84U3YOojeRMq6iGHM16LD00roblgWENJ0-FXyhF7eR4HQoQyfryFFOytKcJClr5drqTY2anibPkmLc2X8LUzupO54Ixrk9bf9rmd47hRid5tyURLOBf-TapQb1bEhZX1x7wNIfsSGPE2X98svjxNXhW8Osrl9wW2OusunEUExa04qet9OKlX4fGdNe8KElvrmmNDDJU4j4t5ps4PF05GkiZ0CNXnjkNmd3eV32JQs5vCT8Xz4XembYspQewW9dyyABJkNXl8TYUOw1nv0owBpK2Y3fB5BrC0Y4dSh5aVBrgnp_nD09hezF3swjKeKaSyDJTp07NOfNEsUhhgq3jx1wC4p7rlx7bfZ2WFrjpuSDeQxjDPmAFjBiDkwBJzvlIHeZJe2_inc2WdBix7iq7-bzlSbeRLIG_Ak7y39pbczzSKSnW8GWcWl1YzpbHvFARFmhm2ZIhKwQB3lNNWGvSC2EEzXrf6XBSh7ws39TsxQw-MBcfhIj-LD8ipmyQ4bQTsHfPecjC-gVNn\" rel=\"nofollow\" target=\"_blank\">rnovak@milestonepharma.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTA3MyM3NTIyMzAxIzUwMDEyMTAzNg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDY4NWRiMDYtNTllOC00YmZjLWFhY2MtNTU4NWU1YmNlMjliLTUwMDEyMTAzNi0yMDI2LTA0LTA3LWVu\/tiny\/Milestone-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MONTREAL and CHARLOTTE, N.C., April 07, 2026 (GLOBE NEWSWIRE) &#8212; Milestone\u00ae Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development of commercialization of innovative cardiovascular medicines, today announced that management will present at the\u00a025th Annual Needham Virtual Healthcare Conference to take place April 13 &#8211; 16, 2026. A webcast of the presentation will be available on April 13th at 3:45 PM EDT. The webcast will be available to watch here and there will be a replay for approximately 90 days on the News &amp; Events section of Milestone&#8217;s website www.milestonepharma.com. If you are interested in meeting with the Milestone team during the conference, please contact your Needham representative. About\u00a0Milestone Pharmaceuticals Milestone Pharmaceuticals Inc.\u00a0(Nasdaq: MIST) is an emerging commercial-stage &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-949477","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MONTREAL and CHARLOTTE, N.C., April 07, 2026 (GLOBE NEWSWIRE) &#8212; Milestone\u00ae Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development of commercialization of innovative cardiovascular medicines, today announced that management will present at the\u00a025th Annual Needham Virtual Healthcare Conference to take place April 13 &#8211; 16, 2026. A webcast of the presentation will be available on April 13th at 3:45 PM EDT. The webcast will be available to watch here and there will be a replay for approximately 90 days on the News &amp; Events section of Milestone&#8217;s website www.milestonepharma.com. If you are interested in meeting with the Milestone team during the conference, please contact your Needham representative. About\u00a0Milestone Pharmaceuticals Milestone Pharmaceuticals Inc.\u00a0(Nasdaq: MIST) is an emerging commercial-stage &hellip; Continue reading &quot;Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-07T13:41:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTA3MyM3NTIyMzAxIzUwMDEyMTAzNg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference\",\"datePublished\":\"2026-04-07T13:41:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/\"},\"wordCount\":210,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NTA3MyM3NTIyMzAxIzUwMDEyMTAzNg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/\",\"name\":\"Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NTA3MyM3NTIyMzAxIzUwMDEyMTAzNg==\",\"datePublished\":\"2026-04-07T13:41:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NTA3MyM3NTIyMzAxIzUwMDEyMTAzNg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NTA3MyM3NTIyMzAxIzUwMDEyMTAzNg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference - Market Newsdesk","og_description":"MONTREAL and CHARLOTTE, N.C., April 07, 2026 (GLOBE NEWSWIRE) &#8212; Milestone\u00ae Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development of commercialization of innovative cardiovascular medicines, today announced that management will present at the\u00a025th Annual Needham Virtual Healthcare Conference to take place April 13 &#8211; 16, 2026. A webcast of the presentation will be available on April 13th at 3:45 PM EDT. The webcast will be available to watch here and there will be a replay for approximately 90 days on the News &amp; Events section of Milestone&#8217;s website www.milestonepharma.com. If you are interested in meeting with the Milestone team during the conference, please contact your Needham representative. About\u00a0Milestone Pharmaceuticals Milestone Pharmaceuticals Inc.\u00a0(Nasdaq: MIST) is an emerging commercial-stage &hellip; Continue reading \"Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-07T13:41:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTA3MyM3NTIyMzAxIzUwMDEyMTAzNg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference","datePublished":"2026-04-07T13:41:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/"},"wordCount":210,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTA3MyM3NTIyMzAxIzUwMDEyMTAzNg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/","name":"Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTA3MyM3NTIyMzAxIzUwMDEyMTAzNg==","datePublished":"2026-04-07T13:41:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTA3MyM3NTIyMzAxIzUwMDEyMTAzNg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTA3MyM3NTIyMzAxIzUwMDEyMTAzNg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/949477","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=949477"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/949477\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=949477"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=949477"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=949477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}